LE WE PMID CA
Ovary (Neoplasia)763Eierstock (Neubildung)

Adenomyosis

Aflibercept

Anti Mueller Hormon

Arthritis (rheumatoid)

Asbestos

Autoantibodies Anti NMDA Receptor

Bacillus calmette guerin

Bartonella henselae

Calcium (Hypercalciemia)

Candida (BASKET)

Coccidioidomycosis

Congenital adrenal hyperplasia

Crohn s disease

Cryptococcosis

Cushing s syndrome

Doxorubicin

Endometrium (Neoplasia)

Fat necrosis subcutaneous of the newborn

FOXL2

Gastrointestinal stromal cell tumor GIST

Germ cell (Neoplasia)

Granulosa cell tumor

Histoplasmosis

Hox

Hyperthecosis

Kidney (Nephrotic syndrome)

KLF6

Langerhans cell histiocytosis

Lepra

Liver (Diseases)

Lung (Lipoid pneumonia)

Lung (Toxicology)

Lung and bronchial system (Neoplasia)

Lymphoma (BASKET)

Lymphoma (Hodgkin)

Mammary gland (Neoplasia)

Mycobacterium avium

Neoplasia (Inherited)

Neoplasia (Invasion and metastasis)

Neoplasia (Paraneoplastic syndromes)

Neoplasia (Tumor markers)

Osteoarthritis

Ovary (Neoplasia)

Ovary (Physilogy)

Ovary (Sonography)

Paracoccoidomycosis

Pneumocystis carinii Pneumocystis jirovicii

Polycystic ovary syndrome

Polymyositis

Proteomics

Psammoma bodies

Pseudolymphoma (Lymphomatoid granulomatosis)

Pseudolymphoma (Plasma cell granuloma)

Pttg

ROMA

Sarcoidosis

Silicone

Slack skin disease

Testis (Neoplasia Seminoma)

Testis (Neoplasia)

Tuberculosis

Uterus (Neoplasia)

VEGF

Wegener s granulomatosis

2008  
1
Hereditary breast and ovarian cancers.
[19074707] Can Fam Physician 54(12): 1691-2 (2008)
2001  
2
1991  
3
New frontiers in ovarian cancer diagnosis and management.
[1721478] Yale J Biol Med 64(2): 127-41 (1991)
1989  
4
Borderline ovarian tumors: a review of treatment.
[2556863] Yale J Biol Med 62(4): 351-65 (1989)
2009  
5
Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin.
[19436618] Ther Clin Risk Manag 5(1): 161-8 (2009)
2006  
6
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
[16545208] Health Technol Assess 10(9): 1-132. iii-iv (2006)
2009  
7
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.
[19383374] Mol Oncol 3(2): 97-137 (2009)
2008  
8
Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456751] Ann Oncol 19 Suppl 2(-): ii14-6 (2008)
2006  
9
Multimodal approach to ovarian cancer.
[16807456] Ann Oncol 17 Suppl 5(-): v199-200 (2006)
2006  
10
Role of gemcitabine in ovarian cancer treatment.
[16807454] Ann Oncol 17 Suppl 5(-): v188-94 (2006)
2006  
11
Challenges for chemotherapy in ovarian cancer.
[16807453] Ann Oncol 17 Suppl 5(-): v181-7 (2006)
2005  
12
Biological characterization of ovarian cancer: prognostic and therapeutic implications.
[15923439] Ann Oncol 16 Suppl 4(-): iv95-101 (2005)
2003  
13
Prognostic factors for patients with advanced stage serous borderline tumours of the ovary.
[12649107] Ann Oncol 14(4): 592-8 (2003)
1998  
14
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.
[9836481] Br J Cancer 78(11): 1479-87 (1998)
1999  
15
Epithelial ovarian cancer: prevention, diagnosis, and treatment.
[11198956] CA Cancer J Clin 49(5): 297-320 (1999)
1995  
16
The treatment of epithelial ovarian cancer.
[7889393] CA Cancer J Clin 45(2): 88-101 (1995)
1995  
17
Early detection of ovarian cancer.
[7889392] CA Cancer J Clin 45(2): 71-87 (1995)
1995  
18
1992  
19
Advances in the screening and treatment of ovarian cancer.
[1393742] CA Cancer J Clin 42(6): 327-49 (1992)
1986  
20
2007  
21
Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.
[17238181] Cancer 109(4): 692-702 (2007)
2007  
22
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer.
[17238177] Cancer 109(4): 645-9 (2007)
2007  
23
EphA2 overexpression is associated with angiogenesis in ovarian cancer.
[17154180] Cancer 109(2): 332-40 (2007)
2006  
24
Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease.
[16998935] Cancer 107(9): 2298-306 (2006)
2005  
25
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
[15726548] Cancer 103(7): 1397-401 (2005)
2004  
26
Carcinosarcoma of the ovary: 19 years of prospective data from a single center.
[15139057] Cancer 100(10): 2148-53 (2004)
2002  
27
Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors).
[12209708] Cancer 95(4): 675-6 (2002)
2000  
28
Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analysis of 40 cases.
[11013369] Cancer 89(7): 1541-6 (2000)
1999  
29
Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
[10326703] Cancer 85(10): 2232-44 (1999)
1998  
30
Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
[9428490] Cancer 82(1): 141-6 (1998)
2008  
31
New insights into the pathogenesis of serous ovarian cancer and its clinical impact.
[18854563] J Clin Oncol 26(32): 5284-93 (2008)
1999  
32
Possible role of ovarian epithelial inflammation in ovarian cancer.
[10469746] J Natl Cancer Inst 91(17): 1459-67 (1999)
1998  
33
Automation and the endangered future of the Pap test.
[9605643] J Natl Cancer Inst 90(10): 738-49 (1998)
2008  
34
Intraperitoneal chemotherapy for women with epithelial ovarian cancer.
[18448554] Oncologist 13(4): 403-9 (2008)
2007  
35
Gonadotropins and ovarian cancer.
[17463396] Endocr Rev 28(4): 440-61 (2007)
2004  
36
Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.
[15111296] Am J Pathol 164(5): 1511-8 (2004)
1977  
37
2009  
38
Ovarian cancer update: lessons from morphology, molecules, and mice.
[19886711] Arch Pathol Lab Med 133(11): 1775-81 (2009)
2007  
39
Current management strategies for ovarian cancer.
[17550756] Mayo Clin Proc 82(6): 751-70 (2007)
2009  
40
Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review.
[19448114] Radiographics 29(3): 759-74; discussion 774-8 (2009)
2008  
41
Imaging findings of complications and unusual manifestations of ovarian teratomas.
[18635624] Radiographics 28(4): 969-83 (2008)
2008  
42
Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.
[18444279] Radiographics 28(1): 289-307 (2008)
2006  
43
Developing an MR imaging strategy for diagnosis of ovarian masses.
[16973774] Radiographics 26(5): 1431-48 (2006)
2004  
44
Functioning ovarian tumors: direct and indirect findings at MR imaging.
[15486238] Radiographics 24 Suppl 1(-): S147-66 (2004)
2004  
45
Recognition of the ovaries and ovarian origin of pelvic masses with CT.
[15486237] Radiographics 24 Suppl 1(-): S133-46 (2004)
2004  
46
From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation.
[14730048] Radiographics 24(1): 225-46 (2004)
2004  
47
PET-CT in recurrent ovarian cancer: initial observations.
[14730047] Radiographics 24(1): 209-23 (2004)
2002  
48
CT and MR imaging of ovarian tumors with emphasis on differential diagnosis.
[12432104] Radiographics 22(6): 1305-25 (2002)
2001  
49
Ovarian teratomas: tumor types and imaging characteristics.
[11259710] Radiographics 21(2): 475-90 (2001)
2000  
50
Imaging evaluation of ovarian masses.
[10992033] Radiographics 20(5): 1445-70 (2000)
1998  
51
Sex cord-stromal and steroid cell tumors of the ovary.
[9821198] Radiographics 18(6): 1523-46 (1998)
1991  
52
Imaging of pediatric ovarian masses.
[1887110] Radiographics 11(4): 533-48 (1991)
2010  
53
Clinical syndromes associated with ovarian neoplasms: a comprehensive review.
[20631359] Radiographics 30(4): 903-19 (2010)
1999  
54
2010  
55
MR imaging of the sonographically indeterminate adnexal mass.
[20720065] Radiology 256(3): 677-94 (2010)
2010  
56
Adnexal masses: US characterization and reporting.
[20089722] Radiology 254(2): 342-54 (2010)
2010  
57
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555098] Ann Oncol 21 Suppl 5(-): v31-6 (2010)
2010  
58
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555088] Ann Oncol 21 Suppl 5(-): v23-30 (2010)
2004  
59
Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics.
[15477297] Ann Oncol 15 Suppl 4(-): iv133-8 (2004)
2010  
60
Genetic counselling for hereditary predisposition to ovarian and breast cancer.
[20943638] Ann Oncol 21 Suppl 7(-): vii334-8 (2010)
2010  
61
The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer.
[20943617] Ann Oncol 21 Suppl 7(-): vii211-17 (2010)
2010  
62
Optimal treatment for relapsing ovarian cancer.
[20943618] Ann Oncol 21 Suppl 7(-): vii218-22 (2010)
2009  
63
Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454452] Ann Oncol 20 Suppl 4(-): 21-3 (2009)
2009  
64
Non-epithelial ovarian cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454453] Ann Oncol 20 Suppl 4(-): 24-6 (2009)
2010  
65
Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles.
[20093594] AJR Am J Roentgenol 194(2): 343-8 (2010)
2010  
66
Clinical decision making using ovarian cancer risk assessment.
[20093593] AJR Am J Roentgenol 194(2): 337-42 (2010)
2010  
67
Current update on borderline ovarian neoplasms.
[20093592] AJR Am J Roentgenol 194(2): 330-6 (2010)
2010  
68
Ultrasound and assessment of ovarian cancer risk.
[20093591] AJR Am J Roentgenol 194(2): 322-9 (2010)
2010  
69
MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.
[20093590] AJR Am J Roentgenol 194(2): 311-21 (2010)
2010  
70
Risk assessment and genetic testing for ovarian cancer.
[20093589] AJR Am J Roentgenol 194(2): 309-10 (2010)
2007  
71
Which ovarian masses need intervention?
[17333642] Cleve Clin J Med 74(2): 149-57 (2007)
2010  
72
Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
[20427501] J Clin Endocrinol Metab 95(7): 3111-7 (2010)
2010  
73
Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma.
[19906851] Eur J Endocrinol 162(2): 213-20 (2010)
2010  
74
The inherited genetics of ovarian and endometrial cancer.
[20456938] Curr Opin Genet Dev 20(3): 231-8 (2010)
2009  
75
The future of targeted therapies in ovarian cancer.
[19592450] Oncologist 14(7): 706-16 (2009)
2010  
76
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker.
[20166213] Cancer 116(8): 1918-25 (2010)
2009  
77
Adult-type granulosa cell tumors and FOXL2 mutation.
[19996294] Cancer Res 69(24): 9160-2 (2009)
2006  
78
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.
[16641903] Br J Cancer 94(10): 1369-74 (2006)
2011  
79
Ovarian cancer: diagnosis and treatment.
[22025930] Dtsch Arztebl Int 108(38): 635-41 (2011)
2009  
80
2008  
81
Malignant ovarian neoplasms: the sonographic voyage of discovery.
[18504774] Ultrasound Obstet Gynecol 31(6): 611-4 (2008)
2009  
82
Pathogenesis of ovarian cancer: clues from selected overexpressed genes.
[20001801] Future Oncol 5(10): 1641-57 (2009)
2009  
83
Aflibercept in epithelial ovarian carcinoma.
[19519199] Future Oncol 5(5): 591-600 (2009)
2007  
84
2011  
85
Occupational exposure to asbestos and ovarian cancer: a meta-analysis.
[21642044] Environ Health Perspect 119(9): 1211-7 (2011)
2010  
86
Human ovarian cancer stem cells.
[20368192] Reproduction 140(1): 33-41 (2010)
2011  
87
2011  
88
The role of surgery in the management of epithelial ovarian cancer.
[21273977] Cancer Control 18(1): 22-30 (2011)
2011  
89
Antiangiogenic therapies in epithelial ovarian cancer.
[21273978] Cancer Control 18(1): 31-43 (2011)
2004  
90
Ovarian cancer management. Practice guidelines for nuclear physicians.
[15243409] Q J Nucl Med Mol Imaging 48(2): 143-9 (2004)
2005  
91
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
[15761467] Mod Pathol 18 Suppl 2(-): S61-79 (2005)
2005  
92
Selected miscellaneous ovarian lesions: small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions.
[15492757] Mod Pathol 18 Suppl 2(-): S113-29 (2005)
2005  
93
Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.
[15492758] Mod Pathol 18 Suppl 2(-): S99-111 (2005)
2005  
94
Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
[15502809] Mod Pathol 18 Suppl 2(-): S81-98 (2005)
2005  
95
Origins and molecular pathology of ovarian cancer.
[15761464] Mod Pathol 18 Suppl 2(-): S19-32 (2005)
2005  
96
Borderline epithelial tumors of the ovary.
[15761465] Mod Pathol 18 Suppl 2(-): S33-50 (2005)
2011  
97
MALDI Imaging Mass Spectrometry (MALDI-IMS)-Application of Spatial Proteomics for Ovarian Cancer Classification and Diagnosis.
[21340013] Int J Mol Sci 12(1): 773-94 (2011)
2011  
98
Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis.
[21541039] Int J Mol Sci 12(2): 1009-29 (2011)
2009  
99
Ovarian cancer: pathology, biology, and disease models.
[19273186] Front Biosci 14(-): 2089-102 (2009)
2009  
100
The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
[19380409] J Nucl Med 50 Suppl 1(-): 64S-73S (2009)
2009  
101
Minireview: epigenetic changes in ovarian cancer.
[19574400] Endocrinology 150(9): 4003-11 (2009)
2008  
102
Early detection of ovarian cancer.
[20477415] Biomark Med 2(3): 291-303 (2008)
2010  
103
Cancer genetics: risks and mechanisms of cancer in women with inherited susceptibility to epithelial ovarian cancer.
[20811826] Cancer Treat Res 156(-): 69-85 (2010)
2009  
104
The biology of ovarian cancer: new opportunities for translation.
[19461667] Nat Rev Cancer 9(6): 415-28 (2009)
2010  
105
Pegylated liposomal doxorubicin in the management of ovarian cancer.
[20957139] Ther Clin Risk Manag 6(-): 463-83 (2010)
2010  
106
Anti-N-methyl-D-aspartate receptor encephalitis in a young woman with an ovarian tumour.
[20683078] Hong Kong Med J 16(4): 313-6 (2010)
2003  
107
A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma.
[12833596] Yonsei Med J 44(3): 539-43 (2003)
2006  
108
2011  
109
Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies.
[21734812] Cancer Manag Res 3(-): 25-38 (2011)
2010  
110
The role of in vitro directed chemotherapy in epithelial ovarian cancer.
[20842282] Rev Obstet Gynecol 3(2): 49-54 (2010)
2010  
111
Practical considerations in ovarian cancer chemotherapy.
[21789133] Ther Adv Med Oncol 2(3): 175-87 (2010)
2009  
112
Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.
[20014424] Mt Sinai J Med 76(6): 557-66 (2009)
2010  
113
Clinicopathologic characteristics and prognostic factors of ovarian fibrosarcoma: the results of a multi-center retrospective study.
[20979607] BMC Cancer 10(-): 585 (2010)
2009  
114
2010  
115
Understanding adenomyosis: a case control study.
[19643403] Fertil Steril 94(4): 1223-8 (2010)
2009  
116
Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.
[19359032] Gynecol Oncol 114(1): 57-60 (2009)
2008  
117
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.
[18317228] Int J Gynecol Pathol 27(2): 151-60 (2008)
2010  
118
Ovarian tumors in pediatric age group - A clinicopathologic study of 10 years' cases in West Bengal, India.
[21209765] Indian J Med Paediatr Oncol 31(2): 54-7 (2010)
2011  
119
HOX genes in ovarian cancer.
[21906307] J Ovarian Res 4(-): 16 (2011)
2008  
120
PTTG: an important target gene for ovarian cancer therapy.
[19014669] J Ovarian Res 1(1): 6 (2008)
2011  
121
ROMA or death: advances in epithelial ovarian cancer diagnosis.
[21288180] Clin Chem Lab Med 49(3): 443-5 (2011)
2008  
122
Prevalence and significance of psammoma bodies in cervicovaginal smears in a cervical cancer screening program with emphasis on a case of primary bilateral ovarian psammocarcinoma.
[18416848] Cytojournal 5(-): 7 (2008)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia